Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Therapeutics - Page 33

Therapeutics

NIH launched its ACTIV-5 ‘Big Effect Trial’ evaluating Humanigen’s Lenzilumabas potential COVID-19 therapy
Biotechnology | COVID-19 | NIH | Therapeutics

NIH launched its ACTIV-5 ‘Big Effect Trial’ evaluating Humanigen’s Lenzilumabas potential COVID-19 therapy

On Oct. 13, 2020, Humanigen announced that the National Institute of Allergy and Infectious Diseases (NIAID), had launched…

Read More NIH launched its ACTIV-5 ‘Big Effect Trial’ evaluating Humanigen’s Lenzilumabas potential COVID-19 therapyContinue

RedHill Biopharma announced partnerships to expand manufacturing for COVID-19 therapeutic candidate opaganib
COVID-19 | Pharmaceutical | Therapeutics

RedHill Biopharma announced partnerships to expand manufacturing for COVID-19 therapeutic candidate opaganib

On Oct. 13, 2020, RedHill Biopharma announced collaborations with two specialist pharmaceutical manufacturers in Europe and Canada to…

Read More RedHill Biopharma announced partnerships to expand manufacturing for COVID-19 therapeutic candidate opaganibContinue

Racial differences in Alzheimer’s research focus of $15 million grant
Biotechnology | Diagnostics | Disease | Neurology | Non-Profit Research | Therapeutics

Racial differences in Alzheimer’s research focus of $15 million grant

On Oct. 12, 2020, the Washington University School of Medicine in St. Louis announced a $14.6 million grant…

Read More Racial differences in Alzheimer’s research focus of $15 million grantContinue

Relation between COVID-19 and Guillain-Barre syndrome in adults: a systematic review published
Biotechnology | COVID-19 | Disease | Therapeutics | Vaccine

Relation between COVID-19 and Guillain-Barre syndrome in adults: a systematic review published

On Oct. 8, 2020, the relation between COVID-19 and Guillain-Barre syndrome in adults: a systematic review was published…

Read More Relation between COVID-19 and Guillain-Barre syndrome in adults: a systematic review publishedContinue

La Jolla Institute for Immunology awarded $1.4 million to study COVID-19 in Latino Americans
Biotechnology | COVID-19 | Disease | Medicine | NIH | Therapeutics

La Jolla Institute for Immunology awarded $1.4 million to study COVID-19 in Latino Americans

On Oct. 8, 2020, the La Jolla Institute for Immunology (LJI) announced it had been granted $1.4 million…

Read More La Jolla Institute for Immunology awarded $1.4 million to study COVID-19 in Latino AmericansContinue

Lilly announced supply of potential COVID-19 antibody therapy for low- and middle-income countries
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics

Lilly announced supply of potential COVID-19 antibody therapy for low- and middle-income countries

On Oct. 8, 2020, Eli Lilly and the Bill & Melinda Gates Foundation, as part of the COVID-19…

Read More Lilly announced supply of potential COVID-19 antibody therapy for low- and middle-income countriesContinue

SIGA announced Public Health Agency of Canada intent to purchase up to 33,300 courses of Oral TPOXX
Biotechnology | Infectious Disease | Therapeutics

SIGA announced Public Health Agency of Canada intent to purchase up to 33,300 courses of Oral TPOXX

On Oct. 8, 2020, SIGA Technologies announced that the Public Health Agency of Canada (PHAC) has issued an…

Read More SIGA announced Public Health Agency of Canada intent to purchase up to 33,300 courses of Oral TPOXXContinue

The Nobel Prize in Chemistry for 2020 was awarded to Emmanuelle Charpentier and Jennifer A Doudna
Biotechnology | Chemical | CRISPR | Genomics | Therapeutics

The Nobel Prize in Chemistry for 2020 was awarded to Emmanuelle Charpentier and Jennifer A Doudna

On Oct. 7, 2020, the Nobel Prize in Chemistry 2020 was awarded to Emmanuelle Charpentier and Jennifer Doudna…

Read More The Nobel Prize in Chemistry for 2020 was awarded to Emmanuelle Charpentier and Jennifer A DoudnaContinue

RedHill Biopharma’s Opaganib COVID-19 study passed second independent committee review
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics

RedHill Biopharma’s Opaganib COVID-19 study passed second independent committee review

On Oct. 7, 2020, RedHill Biopharma announced that the U.S. Phase 2 study with opaganib (Yeliva, ABC294640)1 in…

Read More RedHill Biopharma’s Opaganib COVID-19 study passed second independent committee reviewContinue

RedHill Biopharma opaganib COVID-19 study passed second independent committee review
COVID-19 | Therapeutics

RedHill Biopharma opaganib COVID-19 study passed second independent committee review

On Oct. 7, 2020, RedHill Biopharma announced that the U.S. Phase 2 study with opaganib (Yeliva, ABC294640)1 in…

Read More RedHill Biopharma opaganib COVID-19 study passed second independent committee reviewContinue

Sorrento announced discovery of salicyn-30 small molecule that strongly inhibits SARS-CoV-2 infection
Biotechnology | Therapeutics | Vaccine

Sorrento announced discovery of salicyn-30 small molecule that strongly inhibits SARS-CoV-2 infection

On Oct. 7, 2020, Sorrento Therapeutics announced that it had discovered a small molecule termed Salicyn-30 that demonstrated…

Read More Sorrento announced discovery of salicyn-30 small molecule that strongly inhibits SARS-CoV-2 infectionContinue

Mateon announced first patient enrolled in ARTI-19 multicenter interventional study of Artshield against COVID-19
Biotechnology | COVID-19 | Therapeutics

Mateon announced first patient enrolled in ARTI-19 multicenter interventional study of Artshield against COVID-19

On Oct. 7, 2020, Mateon Therapeutics announced the first patient enrolled this week in its Phase IV study…

Read More Mateon announced first patient enrolled in ARTI-19 multicenter interventional study of Artshield against COVID-19Continue

NIH RADx initiative advanced six new COVID-19 testing technologies
Biotechnology | COVID-19 | Infectious Disease | NIH | Therapeutics

NIH RADx initiative advanced six new COVID-19 testing technologies

On Oct. 6, 2020, the National Institutes of Health (NIH), working in collaboration with the Biomedical Advanced Research…

Read More NIH RADx initiative advanced six new COVID-19 testing technologiesContinue

Hologic Panther Platform and HIV-1 Quant assay used in ‘HIV Cure’ research
Biotechnology | Diagnostics | HIV | Non-Profit Research | Therapeutics

Hologic Panther Platform and HIV-1 Quant assay used in ‘HIV Cure’ research

On Oct. 6, 2020, Hologic announced that two studies in the Journal of Clinical Microbiology demonstrated the utility…

Read More Hologic Panther Platform and HIV-1 Quant assay used in ‘HIV Cure’ researchContinue

Mateon initiated commercialization of Artshield
COVID-19 | Therapeutics

Mateon initiated commercialization of Artshield

On Oct. 5, 2020, Mateon Therapeutics announced that ArtiShieldTM had been approved for manufacture and marketing by the…

Read More Mateon initiated commercialization of ArtshieldContinue

Johnson & Johnson completed acquisition of Momenta Pharmaceuticals for $65 billion
Biotechnology | Therapeutics

Johnson & Johnson completed acquisition of Momenta Pharmaceuticals for $65 billion

On Oct. 1, 2020, Johnson & Johnson announced it had successfully completed its acquisition of Momenta Pharmaceuticals, a…

Read More Johnson & Johnson completed acquisition of Momenta Pharmaceuticals for $65 billionContinue

Sorrento Therapeutics and ViralClear entered agreement to explore combination antibody plus antiviral therapy against COVID-19
Biotechnology | COVID-19 | Therapeutics

Sorrento Therapeutics and ViralClear entered agreement to explore combination antibody plus antiviral therapy against COVID-19

On Sept. 30, 2020, ViralClear Pharmaceuticals and Sorrento Therapeutics announced the companies were exploring the synergistic potential of…

Read More Sorrento Therapeutics and ViralClear entered agreement to explore combination antibody plus antiviral therapy against COVID-19Continue

Bio-Techne announced opening of GMP manufacturing facility in Twin Cities
Biotechnology | Diagnostics | Therapeutics

Bio-Techne announced opening of GMP manufacturing facility in Twin Cities

On Sept. 30, 2020, Bio-Techne announced the opening of its approximately 61,000 square foot state-of-the-art GMP (Good Manufacturing…

Read More Bio-Techne announced opening of GMP manufacturing facility in Twin CitiesContinue

AXIM Biotechnologies filed patent for world’s first face mask designed to capture SARS-CoV-2 COVID-19
COVID-19 | Medical Device | Therapeutics

AXIM Biotechnologies filed patent for world’s first face mask designed to capture SARS-CoV-2 COVID-19

On Sept. 29, 2020, AXIM Biotechnologies announced that it had filed a provisional patent for a first-in-class face…

Read More AXIM Biotechnologies filed patent for world’s first face mask designed to capture SARS-CoV-2 COVID-19Continue

Tonix Pharma completed the purchase of a facility to house advanced development center for vaccine programs
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Tonix Pharma completed the purchase of a facility to house advanced development center for vaccine programs

On Sept. 28, 2020, Tonix Pharmaceuticals announced that it had completed the purchase a 40,000 square foot facility…

Read More Tonix Pharma completed the purchase of a facility to house advanced development center for vaccine programsContinue

Pascal Biosciences confirmed specific cannabinoids combat Coronavirus
Biotechnology | COVID-19 | Infectious Disease | Medicine | Therapeutics

Pascal Biosciences confirmed specific cannabinoids combat Coronavirus

On Sept. 23, 2020, Pascal Biosciences announced the Company had confirmed an earlier report that certain cannabinoids block…

Read More Pascal Biosciences confirmed specific cannabinoids combat CoronavirusContinue

Brazil approved RedHill Biopharma’s phase 2/3 COVID-19 study with opaganib
Biotechnology | COVID-19 | Therapeutics

Brazil approved RedHill Biopharma’s phase 2/3 COVID-19 study with opaganib

On Sept. 22, 2020, RedHill Biopharma announced approval from the Brazilian Health Regulatory Agency (ANVISA) for its ongoing…

Read More Brazil approved RedHill Biopharma’s phase 2/3 COVID-19 study with opaganibContinue

XBiotech to develop human antibody combination as candidate treatment for influenza-COVID-19 co-infection
Biotechnology | COVID-19 | Infectious Disease | Influenza | Therapeutics

XBiotech to develop human antibody combination as candidate treatment for influenza-COVID-19 co-infection

On Sept. 21, 2020, XBiotech announced it was developing a new breakthrough candidate therapy it calls FLUVID for…

Read More XBiotech to develop human antibody combination as candidate treatment for influenza-COVID-19 co-infectionContinue

Lilly and Amgen announced manufacturing collaboration for COVID-19 antibody therapies
Biotechnology | COVID-19 | Therapeutics

Lilly and Amgen announced manufacturing collaboration for COVID-19 antibody therapies

On Sept. 17, 2020, Eli Lilly and Amgen announced a global antibody manufacturing collaboration to significantly increase the…

Read More Lilly and Amgen announced manufacturing collaboration for COVID-19 antibody therapiesContinue

AXIM Biotechnologies filed Emergency Use Authorization with COVID-19 rapid diagnostic test for neutralizing antibodies
COVID-19 | FDA | Therapeutics

AXIM Biotechnologies filed Emergency Use Authorization with COVID-19 rapid diagnostic test for neutralizing antibodies

On Sept. 16, 2020, AXIM Biotechnologies announced that it had filed an Emergency Use Authorization (EUA) application with…

Read More AXIM Biotechnologies filed Emergency Use Authorization with COVID-19 rapid diagnostic test for neutralizing antibodiesContinue

Soligenix announced publication demonstrating thermostabilization of filovirus vaccine antigens
Biotechnology | Disease | Therapeutics | Vaccine

Soligenix announced publication demonstrating thermostabilization of filovirus vaccine antigens

On Sept. 15, 2020, Soligenix announced publication of nonclinical results characterizing filovirus protein antigens (including for Ebola and…

Read More Soligenix announced publication demonstrating thermostabilization of filovirus vaccine antigensContinue

Tonix Pharma enrolled first patient in COV-LOGIC study to assess antibody and T cell responses to SARS-CoV-2
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Tonix Pharma enrolled first patient in COV-LOGIC study to assess antibody and T cell responses to SARS-CoV-2

On Sept. 15, 2020,Tonix Pharmaceuticals announced that the first patient was enrolled in the observational COV-LOGIC study (TNX-C001),…

Read More Tonix Pharma enrolled first patient in COV-LOGIC study to assess antibody and T cell responses to SARS-CoV-2Continue

UTHealth joined NIH trial to test antibodies and other experimental outpatient treatments for COVID-19 pneumonia
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Therapeutics

UTHealth joined NIH trial to test antibodies and other experimental outpatient treatments for COVID-19 pneumonia

On Sept. 15, 2020, the University of Texas Health Science Center at Houston (UTHealth) announced that a study…

Read More UTHealth joined NIH trial to test antibodies and other experimental outpatient treatments for COVID-19 pneumoniaContinue

NIH augmented large scale study of Alzheimer’s disease biomarkers
Biotechnology | Disease | Neurology | NIH | Therapeutics

NIH augmented large scale study of Alzheimer’s disease biomarkers

On Sept. 14, 2020, the National Institutes of Health (NIH) announced that it had added funding for more…

Read More NIH augmented large scale study of Alzheimer’s disease biomarkersContinue

Mateon global study for Artemisinin intervention against COVID-19 cleared for patient enrollment in India
Biotechnology | COVID-19 | Therapeutics

Mateon global study for Artemisinin intervention against COVID-19 cleared for patient enrollment in India

On Sept. 14, 2020, Mateon Therapeutics announced that its global study based on its ARTI-19 protocol for Artemisinin…

Read More Mateon global study for Artemisinin intervention against COVID-19 cleared for patient enrollment in IndiaContinue

Page navigation

Previous PagePrevious 1 … 31 32 33 34 35 … 106 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search